Fund Holdings — Exome Asset Management LLC

Total Portfolio Value:
$116.79M
Total Bought:
$55.61M
Total Sold:
$48.01M
Net Transaction:
+$7.60M
Notable People:
Alex R Forschner
Securities
▲▼
SharesValue
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Eli Lilly and Company(LLY)9,7009,7000$5.65M$7.55M6.46%+$1.89M
Dr. Reddy's Laboratories LimitedADR(RDY)90,00086,000-4,000$6.26M$6.31M5.40%+$45.9K
BeOne Medicines AGADR(ONC)12,80036,800+24,000$2.31M$5.76M4.93%+$3.45M
The Cigna Group(CI)15,30015,3000$4.58M$5.56M4.76%+$975.2K
Alpine Immune Sciences Inc173,500117,000-56,500$3.31M$4.64M3.97%+$1.33M
TG Therapeutics, Inc.(TGTX)203,300230,300+27,000$3.47M$3.50M3.00%+$30.5K
Avidity Biosciences Inc0135,169+135,169$0$3.45M2.95%+$3.45M
Corbus Pharmaceuticals Holdings, Inc.(CRBP)087,846+87,846$0$3.45M2.95%+$3.45M
DexCom, Inc.(DXCM)24,82824,8280$3.08M$3.44M2.95%+$362.7K
Centessa Pharmaceuticals PlcADS0274,900+274,900$0$3.11M2.66%+$3.11M
Celldex Therapeutics, Inc.(CLDX)111,30071,100-40,200$4.41M$2.98M2.56%-$1.43M
Geron Corporation(GERN)607,500886,800+279,300$1.28M$2.93M2.51%+$1.64M
Aerovate Therapeutics Inc098,485+98,485$0$2.91M2.49%+$2.91M
Morphosys AgADS0154,800+154,800$0$2.81M2.40%+$2.81M
Travere Therapeutics, Inc.(TVTX)83,987362,487+278,500$755.0K$2.79M2.39%+$2.04M
Krystal Biotech, Inc.(KRYS)014,700+14,700$0$2.62M2.24%+$2.62M
Intuitive Surgical, Inc.(ISRG)6,3586,3580$2.14M$2.54M2.17%+$392.5K
Tarsus Pharmaceuticals, Inc.(TARS)84,40066,300-18,100$1.71M$2.41M2.06%+$700.9K
Madrigal Pharmaceuticals, Inc.(MDGL)13,2027,900-5,302$3.05M$2.11M1.81%-$945.1K
Inozyme Pharma Inc0273,413+273,413$0$2.09M1.79%+$2.09M
Rhythm Pharmaceuticals, Inc.(RYTM)72,20345,603-26,600$3.32M$1.98M1.69%-$1.34M
Insmed Incorporated(INSM)61,50071,700+10,200$1.91M$1.95M1.67%+$39.3K
Elevation Oncology Inc0369,322+369,322$0$1.89M1.62%+$1.89M
Endeavour Silver Corp.(EXK)026,700+26,700$0$1.84M1.58%+$1.84M
Cytokinetics, Incorporated(CYTK)34,90826,008-8,900$2.91M$1.82M1.56%-$1.09M
REGENXBIO Inc.(RGNX)084,470+84,470$0$1.78M1.52%+$1.78M
Biogen Inc.(BIIB)8,2008,2000$2.12M$1.77M1.51%-$353.7K
Ocular Therapeutix, Inc.(OCUL)0193,600+193,600$0$1.76M1.51%+$1.76M
Agios Pharmaceuticals, Inc.(AGIO)059,902+59,902$0$1.75M1.50%+$1.75M
Natera, Inc.(NTRA)18,65018,6500$1.17M$1.71M1.46%+$537.5K
Penumbra, Inc.(PEN)8,5537,353-1,200$2.15M$1.64M1.41%-$510.4K
Guardant Health, Inc.(GH)079,000+79,000$0$1.63M1.40%+$1.63M
Olema Pharmaceuticals, Inc.(OLMA)0143,400+143,400$0$1.62M1.39%+$1.62M
Arrowhead Pharmaceuticals, Inc.(ARWR)055,700+55,700$0$1.59M1.36%+$1.59M
BridgeBio Pharma, Inc.(BBIO)65,11348,807-16,306$2.63M$1.51M1.29%-$1.12M
Terns Pharmaceuticals Inc0227,821+227,821$0$1.49M1.28%+$1.49M
Marinus Pharmaceuticals Inc0163,100+163,100$0$1.47M1.26%+$1.47M
Inari Med Inc030,100+30,100$0$1.44M1.24%+$1.44M
Quanterix Corporation(QTRX)059,650+59,650$0$1.41M1.20%+$1.41M
Intra-Cellular Therapies Inc28,30020,300-8,000$2.03M$1.40M1.20%-$622.1K
Shockwave Med Inc4,0004,0000$762.2K$1.30M1.12%+$540.3K
Yarrow Bioscience Inc(YARW)118,100415,434+297,334$275.2K$1.28M1.09%+$1.00M
Regulus Therapeutics Inc178,404402,504+224,100$228.4K$1.16M0.99%+$930.9K
Q32 Bio Inc.(QTTB)065,021+65,021$0$1.11M0.95%+$1.11M
Zai Lab LimitedADR(ZLAB)065,300+65,300$0$1.05M0.90%+$1.05M
Enliven Therapeutics Inc057,635+57,635$0$1.01M0.87%+$1.01M
Ventyx Biosciences Inc0163,922+163,922$0$901.6K0.77%+$901.6K
Ultragenyx Pharmaceutical Inc.(RARE)017,800+17,800$0$831.1K0.71%+$831.1K
NovaBridge BiosciencesADS(NBP)0325,762+325,762$0$605.9K0.52%+$605.9K
Adagene IncADS0155,383+155,383$0$435.1K0.37%+$435.1K
Sagimet Biosciences Inc.COM SER A(SGMT)060,900+60,900$0$330.1K0.28%+$330.1K
Pacific Biosciences of California, Inc.(PACB)75,30075,3000$738.7K$282.4K0.24%-$456.3K
Avrobio Inc061,135+61,135$0$78.3K0.07%+$78.3K
Apellis Pharmaceuticals Inc
COM
7,2490-7,249$433.9K$0—-$433.9K
Biohaven Ltd.(BHVN)45,4670-45,467$1.95M$0—-$1.95M
Cabaletta Bio, Inc.(CABA)46,7000-46,700$1.06M$0—-$1.06M
Catalyst Pharmaceuticals Inc105,5000-105,500$1.77M$0—-$1.77M
Establishment Labs Holdings Inc.(ESTA)27,6000-27,600$714.6K$0—-$714.6K
EyePoint, Inc.(EYPT)26,4000-26,400$610.1K$0—-$610.1K
Gracell Biotechnologies IncADS40,9740-40,974$411.4K$0—-$411.4K
Igm Biosciences Inc135,5960-135,596$1.13M$0—-$1.13M
Immatics N.V.SHS(IMTX)129,9000-129,900$1.37M$0—-$1.37M
Immunogen Inc186,9000-186,900$5.54M$0—-$5.54M
Inhibrx Inc73,1580-73,158$2.78M$0—-$2.78M
Kinnate Biopharma Inc83,8480-83,848$198.7K$0—-$198.7K
Lantheus Holdings, Inc.(LNTH)29,1000-29,100$1.80M$0—-$1.80M
Legend Biotech CorporationADS(LEGN)37,9000-37,900$2.28M$0—-$2.28M
MacroGenics, Inc.(MGNX)125,9000-125,900$1.21M$0—-$1.21M
Mirati Therapeutics Inc15,8960-15,896$933.9K$0—-$933.9K
MoonLake ImmunotherapeuticsCL A(MLTX)9,7440-9,744$588.4K$0—-$588.4K
Pliant Therapeutics, Inc.(PLRX)49,5800-49,580$897.9K$0—-$897.9K
Procaps Group SaSHS126,9010-126,901$516.5K$0—-$516.5K
Prothena Corp PlcSHS
SHS
36,3840-36,384$1.32M$0—-$1.32M
Rocket Pharmaceuticals, Inc.(RCKT)91,8000-91,800$2.75M$0—-$2.75M
Sage Therapeutics Inc35,2570-35,257$764.0K$0—-$764.0K
Shattuck Labs, Inc.(STTK)223,3000-223,300$1.59M$0—-$1.59M
Structure Therapeutics IncADS68,1000-68,100$2.78M$0—-$2.78M
Sutro Biopharma, Inc.(STRO)153,6000-153,600$658.9K$0—-$658.9K
Taysha Gene Therapies, Inc.(TSHA)693,3000-693,300$1.23M$0—-$1.23M
Vertex Pharmaceuticals Incorporated(VRTX)3,9000-3,900$1.59M$0—-$1.59M
Page 1 of 1
Exome Asset Management LLC — 13F Holdings — Q1 2024 | TickerTrail